These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New developments in the treatment of Alzheimer's disease. J Clin Psychiatry; 2009 Feb; 70(2):281-90. PubMed ID: 19265644 [No Abstract] [Full Text] [Related]
3. Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial. Pomara N; Ott BR; Peskind E; Resnick EM Alzheimer Dis Assoc Disord; 2007; 21(1):60-4. PubMed ID: 17334274 [TBL] [Abstract][Full Text] [Related]
4. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies. Tariot PN J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847 [TBL] [Abstract][Full Text] [Related]
5. Memantine: the next trend in academic performance enhancement? Ota KS; Godwin T J Am Osteopath Assoc; 2006 Jun; 106(6):358-9. PubMed ID: 16790543 [No Abstract] [Full Text] [Related]
7. [The action of memantine on the cognitive disorders of patients with dementia: reflections following two years' experience in Spain]. Robles-Bayón A Rev Neurol; 2006 Mar 1-15; 42(5):288-96. PubMed ID: 16538592 [TBL] [Abstract][Full Text] [Related]
8. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia]. Tanović A; Alfaro V Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529 [TBL] [Abstract][Full Text] [Related]
9. Different conclusions about memantine. Lexchin J Can Fam Physician; 2007 Mar; 53(3):403-4; author reply 404. PubMed ID: 17872671 [No Abstract] [Full Text] [Related]
10. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine. Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273 [TBL] [Abstract][Full Text] [Related]
11. Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer's disease. Francis PT Neurodegener Dis; 2008; 5(3-4):241-3. PubMed ID: 18322401 [TBL] [Abstract][Full Text] [Related]
12. Drugs for cognitive loss and dementia. Treat Guidel Med Lett; 2007 Feb; 5(54):9-14. PubMed ID: 17261969 [No Abstract] [Full Text] [Related]
17. [Managing psychiatric patients: a mix of acceptance, congruence and empathy]. Walter A Pflege Z; 2001 May; 54(5):327-30. PubMed ID: 12025546 [No Abstract] [Full Text] [Related]
18. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease. Rabins PV; Lyketsos CG Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739 [No Abstract] [Full Text] [Related]
19. Memantine (Ebixa) in clinical practice - results of an observational study. Calabrese P; Essner U; Forstl H Dement Geriatr Cogn Disord; 2007; 24(2):111-7. PubMed ID: 17622714 [TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI). Ferris S; Schneider L; Farmer M; Kay G; Crook T Int J Geriatr Psychiatry; 2007 May; 22(5):448-55. PubMed ID: 17117395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]